Osaic Holdings
CSBR icon

Osaic Holdings’s Champions Oncology CSBR Stock Holding History

Osaic Holdings’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$868 – 7766
2025
Q1 		$868 Hold
100
– – ﹤0.01% 6866
2024
Q4 		$857 Buy
+100
New +$503 ﹤0.01% 6891
2020
Q4 		– Sell
-25
Closed – – 6421
2020
Q3 		$0 Sell
25
-1,000
-98% -$8.9K ﹤0.01% 6238
2020
Q2 		$10K Buy
1,025
+1,013
+8,442% +$8.63K ﹤0.01% 5168
2020
Q1 		$0 Buy
+12
New +$84 ﹤0.01% 6081

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Osaic Holdings's CSBR Position: Q2 2025 in Review

Osaic Holdings sold out of Champions Oncology (CSBR) in Q2 2025, closing a stake of 100 shares — an estimated $868 sold.

Osaic Holdings first reported a position in CSBR in Q1 2020 and held it in 5 quarters. The position peaked at $10K in Q2 2020. 30 funds tracked by Wall St. Rank hold CSBR as of Q2 2025.

  • Osaic Holdings reported no remaining Champions Oncology position as of Q2 2025 after selling out during the quarter.
  • Osaic Holdings sold 100 Champions Oncology shares in Q2 2025, an estimated $868.
  • Osaic Holdings first reported a position in Champions Oncology in Q1 2020 and held it in 5 quarters.
  • Osaic Holdings's Champions Oncology position peaked at $10K in Q2 2020.
  • 30 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2025.

Based on Osaic Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.